购物车
- 全部删除
- 您的购物车当前为空
FK 3311 (COX-2 Inhibitor V) 是一种细胞渗透性和口服磺胺类药物,可作为 COX-2 抑制剂和非甾体抗炎药。
为众多的药物研发团队赋能,
让新药发现更简单!
FK 3311 (COX-2 Inhibitor V) 是一种细胞渗透性和口服磺胺类药物,可作为 COX-2 抑制剂和非甾体抗炎药。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 235 | 现货 | |
2 mg | ¥ 333 | 现货 | |
5 mg | ¥ 541 | 现货 | |
10 mg | ¥ 866 | 现货 | |
25 mg | ¥ 1,480 | 现货 | |
50 mg | ¥ 2,280 | 现货 | |
100 mg | ¥ 3,380 | 现货 | |
200 mg | ¥ 4,850 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 729 | 现货 |
产品描述 | FK 3311 (COX-2 Inhibitor V) is a cell permeable and orally available sulfonanilide that acts as a COX-2 inhibitor and non-steroidal anti-inflammatory drug (NSAID) |
体内活性 | 在FK3311(FK)高剂量组中,存活率显著提高(p<0.05),复灌后30分钟的血清GOT水平显著降低(p<0.05)。复灌4小时后,该组的GPT水平和肝组织流量明显优于对照组(p<0.05)。无论是复灌后30分钟还是4小时,FK高剂量组的血清TxB(2)水平与对照组相比均显著降低(p<0.05)[1]。 |
动物实验 | Inbred male Lewis rats weighing 200-260 g were used. The donor liver was perfused with cold University of Wisconsin (UW) solution and then stored in the same solution at 4 degrees C for 18 hr. After the preservation period, orthotopic liver transplantation was performed. Animals were divided into three groups: the control group; the FK low-dose group (1 mg/kg FK3311 i.v. 20 min before reperfusion); and the FK high-dose group (3 mg/kg FK3311. 20 min before reperfusion). Survival rate, serum GOT and GPT levels, liver tissue blood flow, and serum thromboxane B(2) (TxB(2)) levels were compared among groups[1]. |
别名 | N-[4-乙酰基-2-(2,4-二氟苯氧基)苯基]-甲烷磺酰胺, FK-3311, COX-2 Inhibitor V |
分子量 | 341.33 |
分子式 | C15H13F2NO4S |
CAS No. | 116686-15-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (292.97 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.